Bacillus Calmette-Guerin: Phase I data

Researchers at Harvard and colleagues reported data from a double-blind, placebo-controlled, U.S. Phase I trial showing that 2 doses of a BCG vaccine led to transient increases in dead insulin autoreactive T cells

Read the full 339 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE